- Who can participate: Adults aged 18 to 65 who have been diagnosed with chronic pain for at least six months and have not responded adequately to standard treatments are eligible to participate. Participants must be in generally good health, aside from their chronic pain condition.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study involves regular assessments of pain levels, physical examinations, and questionnaires to monitor health and treatment effects.
